×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [human subject protection]
Home >
human subject protection
Compliance Considerations in Pharmaceutical Product Development Compliance Considerations in Pharmaceutical Product Development John C. (Jack) Garvey,
219 views
FDA Compliance Actions Against IRBs and Clinical Investigators Paul W. Goebel, Jr., CIP Vice President
[email protected]
Chesapeake Research Review,
217 views
Understanding Our HRPP and Your Role in the Accreditation Process.
221 views
FDA Final Rule & Revised NCI Guidelines for Expedited Reporting of Adverse Events S. Percy Ivy, MD Associate Chief, Senior Investigator Investigational.
215 views
Ann Johnson IRB Administrator, IRB Member. Objectives 1. Identify the components necessary for management and oversight of tissue repositories used for.
217 views
NIH RESEARCH CONTRACTS Rosemary M. Hamill Procurement Analyst Division of Acquisition Policy and Evaluation Office of Acquisition Management and Policy.
224 views
NIH RESEARCH CONTRACTS Rosemary M. Hamill Procurement Analyst Office of Acquisitions National Cancer Institute NIH/DHHS.
219 views
Biosafety in Biomedical Laboratories June 2, 2009 Marshall University Summer Students/Recent Hires Please complete the sign in sheet.
214 views
“Minor Change” What Exactly Does That Mean? Presentation to SACHRP by Gary L. Chadwick, PharmD, MPH, CIP Professor and Associate Provost University of.
221 views
Centre for Investigational New Product National Pharmaceutical Control Bureau, MOH.
219 views
R
276 views
Ethics in research educ 210
48 views
Next >